Genomic Correlates with Differential Virulence in Melioidosis Animal Models
类鼻疽动物模型中基因组与差异毒力的相关性
基本信息
- 批准号:8260261
- 负责人:
- 金额:$ 34.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnimalsAustraliaBurkholderia pseudomalleiClinicClinical ResearchCollectionDataDermalDifferential MortalityDiseaseEmerging Communicable DiseasesFrequenciesGene ExpressionGenomeGenomic IslandsGenomicsGenotypeHumanInbred MouseIncidenceInfectionInfectious Diseases ResearchInterventionKnowledgeLesionLungMelioidosisModelingMouse StrainsMusNear DrowningOutcomePatternPhenotypePopulationProteomicsRattusResearchResolutionRouteSurveysThailandVirulenceVirulence Factorsbiodefensehealth care qualityhuman diseaseknockout genemortalitynonhuman primatepathogenprospectiveskin abscess
项目摘要
Burkholderia pseudomallei, are commonly observed in Thailand and Australia (but also other equatorial
regions), where mortality rates are 40% and 14%, respectively. The difference in these mortality rates has been
attributed to healthcare quality (28), but our data demonstrate that pathogen populations also differ between
these regions (145). In addition, prospective clinical studies in Australia are under way with promising
preliminary associations between strain types and outcomes (Currie, Tuanyok, Wagner, Keim, et al.,
unpublished data). It is well established that B. pseudomallei contains an "open" genome (90) that recombines
at a high frequency, leading to great diversity within and among pathogen populations. We believe differential
virulence among pathogen populations (strains) contributes to differential mortality rates around the globe.
Our primary hypothesis is that highly diverse B. pseudomallei strains have different virulence levels, and that
these virulence differences will depend on the strain genomic composition (e.g., genomic islands).
Multiple infection routes have been documented. Melioidosis infection routes are frequently hard to
determine in the clinic, but inhalational and percutaneous routes both occur. Melioidosis incidence increases
following tropical storms and near-drowning (30, 31), consistent with a pulmonary route. However, most
melioidosis cases probably result from percutaneous inoculation (39), which is consistent with the presence of
skin abscesses and dermal lesions (28). Virulence varies according to the infective route in animals and
depends on the particular strain (see CK#3 and (11,146)).
Animal models are important. Because human studies can be problematic, animal models are a
common and powerful research approach to understand pathogen virulence. The mouse is the least expensive
model, yet a very powerful one, but a single model may not always accurately represent diseases in other
animals, including humans. Developing additional animal models (e.g., multiple mouse strains, rat, nonhuman
primates) can support initial studies in the mouse and make our disease understanding more
generalized and representative for human disease intervention. Knowledge and understanding of animal
models is critical to infectious disease research.
Burkholderia pseudomallei通常在泰国和澳大利亚(以及其他赤道)观察到
区域),死亡率分别为40%和14%。这些死亡率的差异是
归因于医疗保健质量(28),但我们的数据表明,病原体种群也有所不同
这些地区(145)。此外,澳大利亚的前瞻性临床研究正在进行中
应变类型和结果之间的初步关联(Currie,Tuanyok,Wagner,Keim等,等等
未发表的数据)。 B. pseudomallei含有一个“开放”基因组(90),重新组合
在高频率下,导致病原体种群内部和中间的多样性。我们相信差异
病原体种群(菌株)之间的毒力有助于全球的差异死亡率。
我们的主要假设是,高度多样的假疟原虫菌株具有不同的毒力水平,并且
这些毒力差异将取决于菌株基因组组成(例如基因组岛)。
已记录了多个感染路线。 Melioidosis感染途径通常很难
在诊所确定,但都会出现吸入和经皮路线。 Melioidisois发病率增加
在热带风暴和几乎陷入困境之后(30,31),与肺部路线一致。但是,大多数
Melioidosis病例可能是由经皮接种引起的(39),这与存在
皮肤脓肿和皮肤病变(28)。毒力根据动物的感染途径而变化,
取决于特定的菌株(请参阅CK#3和(11,146))。
动物模型很重要。因为人类研究可能是有问题的,所以动物模型是
常见且强大的研究方法来理解病原体毒力。鼠标是最便宜的
模型,但非常有力的模型,但是单个模型可能并不总是准确地代表其他模型
包括人类在内的动物。开发其他动物模型(例如,多种小鼠菌株,大鼠,非人类
灵长类动物)可以支持小鼠中的初始研究,并使我们的疾病了解更多
人类疾病干预的广义和代表。对动物的知识和理解
模型对于传染病研究至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Stephen Keim其他文献
Paul Stephen Keim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul Stephen Keim', 18)}}的其他基金
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689662 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689664 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356626 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356625 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10891793 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
北美新兴隐球菌亚型的功能基因组分析
- 批准号:
8386240 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
Functional genomic analyses of emerging Cryptococcus subtypes in North America
北美新兴隐球菌亚型的功能基因组分析
- 批准号:
8505370 - 财政年份:2012
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8281561 - 财政年份:2010
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8477122 - 财政年份:2010
- 资助金额:
$ 34.6万 - 项目类别:
Molecular Antibiotic Resistance Arrays for clinical microbiology laboratories
用于临床微生物学实验室的分子抗生素耐药性芯片
- 批准号:
8088115 - 财政年份:2010
- 资助金额:
$ 34.6万 - 项目类别:
相似国自然基金
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
基于供应链视角的动物源性食品中抗微生物药物耐药性传导机制及监管策略研究
- 批准号:72303209
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于基因组数据自动化分析为后生动物类群大规模开发扩增子捕获探针的实现
- 批准号:32370477
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
- 批准号:32371605
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
闸坝建设对河口大型底栖动物功能与栖息地演变的影响-以粤西鉴江口为例
- 批准号:42306159
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Adipose Targeted Gene Therapy for Lipodystrophy
新型脂肪靶向基因疗法治疗脂肪营养不良
- 批准号:
10820263 - 财政年份:2023
- 资助金额:
$ 34.6万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10594002 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10487660 - 财政年份:2022
- 资助金额:
$ 34.6万 - 项目类别:
Furopyrimidines as novel inhibitors of henipaviruses
呋喃嘧啶作为亨尼帕病毒的新型抑制剂
- 批准号:
10327725 - 财政年份:2021
- 资助金额:
$ 34.6万 - 项目类别: